Basel, Switzerland

Anaïs Lopez

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Anaïs Lopez - Pioneering Innovations in Hepatitis B Treatment

Introduction

Anaïs Lopez is a notable inventor based in Basel, Switzerland, recognized for his contributions to the field of medical research and biotechnology. With a total of 2 patents to his name, Lopez focuses on innovative solutions for treating chronic viral infections, notably hepatitis B.

Latest Patents

Lopez's latest patents include a groundbreaking invention involving nucleic acid molecules aimed at reducing PAPD5 and PAPD7 mRNA, which are crucial in the context of hepatitis B infection. The present invention outlines nucleic acid molecules that are complementary to both PAP associated domain containing 5 (PAPD5) and PAP associated domain containing 7 (PAPD7). These molecules lead to the inhibition of expression for both PAPD5 and PAPD7, employing a single nucleic acid molecule. Furthermore, the invention lays the groundwork for PAPD5 and PAPD7 specific nucleic acid molecules intended for use in the treatment and prevention of hepatitis B virus (HBV) infections, especially chronic HBV infections. Included is a pharmaceutical composition designed for the treatment and prevention of HBV infections.

Career Highlights

Anaïs Lopez operates at Hoffmann-La Roche Inc., a leading global healthcare company that operates worldwide under the name Roche. His role there involves significant research and development in therapies targeting viral infections, showcasing his expertise in biotechnology and pharmacology.

Collaborations

Throughout his career, Lopez has collaborated with esteemed colleagues such as Susanne Kammler and Henrik Mueller. Their teamwork highlights a commitment to advancing healthcare solutions through innovative research and development.

Conclusion

Anaïs Lopez stands out as a key inventor in the biotechnology sector, impacting the treatment of hepatitis B with his innovative nucleic acid molecules. His work not only contributes to advanced scientific knowledge but also addresses critical health challenges faced by millions worldwide. With ongoing collaboration and development, Lopez's inventions may pave the way for more effective treatments for chronic viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…